glp-1 fda approved The said it's aware of some Americans using unapproved versions of medications, which is said can be "risky for patients." In a major milestone for

For the right patient, medications such as semaglutide and tirzepatide may be useful tools when they are prescribed, monitored, and adjusted as part of a physician-guided plan

administration and observed a half-life of 1.9 h for GLP-1MK-801, which is longer than the parent GLP-1 analogue, but comparable to that of the GLP-1inactive MK-801 conjugate (Fig

Do not use while pregnant or nursing without medical guidance

They may adjust your dose or recommend alternatives

The American Diabetes Association (ADA) guidelines recommend GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes who have established atherosclerotic cardiovascular disease or indicators of high cardiovascular risk, or for those requiring additional glucose-lowering beyond metformin

Which one do we choose